Marcelo H Losso
Overview
Explore the profile of Marcelo H Losso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
1442
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kelley C, Acevedo-Quinones M, Agwu A, Avihingsanon A, Benson P, Blumenthal J, et al.
N Engl J Med
. 2024 Nov;
PMID: 39602624
Background: Twice-yearly subcutaneous lenacapavir has been shown to be efficacious for prevention of HIV infection in cisgender women. The efficacy of lenacapavir for preexposure prophylaxis (PrEP) in cisgender men, transgender...
2.
Papot E, Tovar-Sanchez T, Woods J, Thaurignac G, Eriobu N, Borok M, et al.
AIDS
. 2024 Nov;
39(4):448-456.
PMID: 39576151
Objective: Data on the impact of coronavirus disease 2019 (COVID-19) in people with HIV (PWH) are lacking in resource-constrained settings. We utilized existing randomized clinical trials (RCTs) on antiretroviral therapies...
3.
Bullo M, Kierszenowicz T, Acosta M, Rolon M, Cecchini D, Rodriguez C, et al.
HIV Med
. 2024 Apr;
25(8):927-934.
PMID: 38657752
Background: From October 2020 to October 2022, we conducted an implementation study to offer telemedicine (TM) across four HIV units of general public hospitals in Buenos Aires. The intervention used...
4.
Magaret C, Li L, deCamp A, Rolland M, Juraska M, Williamson B, et al.
Nat Commun
. 2024 Mar;
15(1):2175.
PMID: 38467646
In the ENSEMBLE randomized, placebo-controlled phase 3 trial (NCT04505722), estimated single-dose Ad26.COV2.S vaccine efficacy (VE) was 56% against moderate to severe-critical COVID-19. SARS-CoV-2 Spike sequences were determined from 484 vaccine...
5.
Pastor I, Kundro M, Viloria G, Losso M
Medicina (B Aires)
. 2022 Oct;
82(5):774-776.
PMID: 36220037
Monkeypox is an endemic disease in several African countries. In May 2022, an outbreak was reported in dozens of non-endemic countries. On July 23, 2022, the WHO Director-General declared this...
6.
Papot E, Jacoby S, Arlinda D, Avihingsanon A, Azwa I, Borok M, et al.
HIV Res Clin Pract
. 2022 Aug;
23(1):37-46.
PMID: 35938597
A rapidly changing landscape of antiretrovirals and their procurement at scale has permitted the evaluation of new optimised second-line antiretroviral therapy (ART) in low- and middle-income countries. DEFT is an...
7.
Pelchen-Matthews A, Larsen J, Shepherd L, Begovac J, Pedersen K, De Wit S, et al.
HIV Res Clin Pract
. 2021 Nov;
22(6):160-168.
PMID: 34779362
Hypersensitivity reaction (HSR) and hepatotoxicity are rare, but potentially serious side-effects of antiretroviral use. To investigate discontinuations due to HSR, hepatotoxicity or other reasons among users of dolutegravir (DTG) vs....
8.
Landovitz R, Donnell D, Clement M, Hanscom B, Cottle L, Coelho L, et al.
N Engl J Med
. 2021 Aug;
385(7):595-608.
PMID: 34379922
Background: Safe and effective long-acting injectable agents for preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection are needed to increase the options for preventing HIV infection. Methods: We conducted...
9.
Kowalska J, Pelchen-Matthews A, Ryom L, Losso M, Trofimova T, Mitsura V, et al.
AIDS
. 2021 May;
35(12):2025-2033.
PMID: 34033590
Objective: To evaluate time trends in pregnancies and pregnancy outcomes among women with HIV in Europe. Design: European multicentre prospective cohort study. Methods: EuroSIDA has collected annual cross-sectional audits of...
10.
Simonovich V, Burgos Pratx L, Scibona P, Beruto M, Vallone M, Vazquez C, et al.
N Engl J Med
. 2020 Nov;
384(7):619-629.
PMID: 33232588
Background: Convalescent plasma is frequently administered to patients with Covid-19 and has been reported, largely on the basis of observational data, to improve clinical outcomes. Minimal data are available from...